Role of PET-CT with 18F-fluorocholine in biochemical recurrence after treatment of prostate cancer with curative intent.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Actas Urologicas Espanolas

• Publication date

  2017-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.ACUROE.2017.06.002
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Evaluation of Prostate Cancer Bone Metastases with 18F-NaF and 18F-Fluorocholine PET/CT

  2016cited by this paper
• 11C-choline PET/CT and multiparametric MRI in patients with biochemical relapse of prostate cancer

  2015cited by this paper
• Clinical utility of 18F‐fluorocholine positron‐emission tomography/computed tomography (PET/CT) in biochemical relapse of prostate cancer after radical treatment: results of a multicentre study

  2015cited by this paper
• Choline‐positron emission tomography/CT in patients with relapsing prostate cancer: to be performed with therapeutic consequences only

  2015cited by this paper
• 11C-colina PET/TAC y RM multiparamétrica en la recidiva bioquímica del cáncer de próstata

  2015cited by this paper
• The role of positron emission tomography/computed tomography imaging with radiolabeled choline analogues in prostate cancer.

  2014cited by this paper
• National Prostate Cancer Registry 2010 in Spain

  2013cited by this paper
• Registro nacional de cáncer de próstata 2010 en España

  2013cited by this paper
• Impact of total PSA, PSA doubling time and PSA velocity on detection rates of 11C-Choline positron emission tomography in recurrent prostate cancer

  2013cited by this paper
• Influence of PSA, PSA velocity and PSA doubling time on contrast-enhanced 18F-choline PET/CT detection rate in patients with rising PSA after radical prostatectomy

  2012cited by this paper
• Relationship between PSA kinetics and [18F]fluorocholine PET/CT detection rates of recurrence in patients with prostate cancer after total prostatectomy

  2012cited by this paper
• The role of choline positron emission tomography/computed tomography in the management of patients with prostate-specific antigen progression after radical treatment of prostate cancer.

  2011cited by this paper
• Dual Tracer 11C-Choline and FDG-PET in the Diagnosis of Biochemical Prostate Cancer Relapse After Radical Treatment

  2010cited by this paper
• PSA doubling time for prediction of [11C]choline PET/CT findings in prostate cancer patients with biochemical failure after radical prostatectomy

  2010cited by this paper
• Predictive factors of [11C]choline PET/CT in patients with biochemical failure after radical prostatectomy

  2010cited by this paper
• Is there a role for 11C-choline PET/CT in the early detection of metastatic disease in surgically treated prostate cancer patients with a mild PSA increase <1.5 ng/ml?

  2010cited by this paper
• Influence of Trigger PSA and PSA Kinetics on 11C-Choline PET/CT Detection Rate in Patients with Biochemical Relapse After Radical Prostatectomy

  2009cited by this paper
• PET-CT for treatment planning in prostate cancer.

  2009cited by this paper
• A model that predicts the probability of positive imaging in prostate cancer cases with biochemical failure after initial definitive local therapy.

  2008cited by this paper
• Evaluation of [18F]-choline PET/CT for staging and restaging of prostate cancer

  2008cited by this paper
• Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy.

  2007cited by this paper
• The detection rate of [11C]Choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer

  2007cited by this paper
• Pretreatment PSA Velocity and Risk of Death From Prostate Cancer Following External Beam Radiation Therapy

  2007cited by this paper
• [18F]fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients

  2006cited by this paper
• Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy.

  2006cited by this paper
• Positron Emission Tomography/Computed Tomography with F-18-fluorocholine for Restaging of Prostate Cancer Patients: Meaningful at PSA < 5 ng/ml?

  2005cited by this paper
• Do younger men have better biochemical outcomes after radical prostatectomy?

  2004cited by this paper
• Radionuclide bone scintigraphy in patients with biochemical recurrence after radical prostatectomy: when is it indicated?

  2004cited by this paper
• 11C-choline positron emission tomography for the evaluation after treatment of localized prostate cancer.

  2003cited by this paper
• ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of prostate cancer.

  2003cited by this paper
• Value of [11C]choline-positron emission tomography for re-staging prostate cancer: a comparison with [18F]fluorodeoxyglucose-positron emission tomography.

  2003cited by this paper
• Experience with carbon-11 choline positron emission tomography in prostate carcinoma

  2000cited by this paper
• Limited role of radionuclide bone scintigraphy in patients with prostate specific antigen elevations after radical prostatectomy.

  1998cited by this paper

• Usefulness of 18F-Choline Positron Emission Tomography - Computed Tomography in the therapeutic management of patients with biochemical recurrence of prostate adenocarcinoma treated with brachytherapy.

  2020cites this paper
• Usefulness of 18F-choline positron emission tomography-computed tomography in the therapeutic management of patients with biochemical recurrence of prostate adenocarcinoma treated with brachytherapy

  2020cites this paper
• Usefulness of 18F-fluorocoline PET/CT in prostate cancer patients with biochemical recurrence: Influence of PSA kinetics and hormone therapy.

  2019cites this paper
• Usefulness of 18F-fluorocoline PET/CT in prostate cancer patients with biochemical recurrence: Influence of PSA kinetics and hormone therapy

  2019cites this paper